Neuronetics insider buys 100,000 STIM shares

Neuronetics, Inc. large shareholder Jorey Chernett bought 100,000 shares of common stock in an open-market transaction.

Rhea-AI Filing Summary

Neuronetics, Inc. large shareholder Jorey Chernett bought 100,000 shares of common stock in an open-market transaction. The shares were purchased at an average price of $1.17 per share. Following this buy, Chernett directly holds 10,553,988 Neuronetics shares.

Insights

Insider transactions analyst

Large Neuronetics holder makes a modest open-market share purchase.

A significant shareholder of Neuronetics, Inc., Jorey Chernett, executed an open-market purchase of 100,000 shares of common stock at $1.17 per share. This is categorized as a straightforward buy transaction with no derivatives involved.

After the trade, Chernett's direct holdings total 10,553,988 shares, indicating that the purchase adds incrementally to an already large position. With no derivative positions listed and no trading-plan footnotes provided in the data, this appears to be a routine increase in exposure rather than a transformative move.

Insider Trade Summary

Net Buyer: 100,000 shares

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 100,000 shs ($117K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	100,000	$1.17	$117K

Holdings After Transaction: Common Stock — 10,553,988 shares (Direct)

Key Figures

Shares purchased: 100,000 shares Purchase price: $1.17 per share Total holdings after trade: 10,553,988 shares +1 more

4 metrics

Shares purchased 100,000 shares Open-market buy of Neuronetics common stock

Purchase price $1.17 per share Price paid for the 100,000-share transaction

Total holdings after trade 10,553,988 shares Direct Neuronetics common stock owned by Chernett after purchase

Transaction code P Classified as a purchase in open market or private transaction

Key Terms

open-market purchase, ten percent owner, Form 4

3 terms

open-market purchase financial

"transaction_action is listed as an open-market purchase of common stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner regulatory

"reporting person is marked as a ten percent owner of Neuronetics"

Form 4 regulatory

"insider activity is disclosed through a Form 4 insider transaction report"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did STIM major holder Jorey Chernett report?

Chernett reported an open-market purchase of 100,000 Neuronetics (STIM) common shares. The transaction was coded as a purchase at $1.17 per share, increasing his direct ownership stake in the company.

At what price did Jorey Chernett buy Neuronetics (STIM) shares?

He bought the shares at an average price of $1.17 per Neuronetics common share. This price applies to the full 100,000-share open-market transaction disclosed in the Form 4 data.

How many Neuronetics (STIM) shares does Jorey Chernett own after this trade?

Following the reported purchase, Chernett directly owns 10,553,988 Neuronetics common shares. This figure reflects his total direct holdings after adding the 100,000 shares bought in the open-market transaction.

Was the Neuronetics (STIM) insider transaction a buy or a sell?

The transaction was a buy, specifically an open-market purchase of 100,000 Neuronetics shares. The Form 4 data classifies it with transaction code P and identifies the direction as a net-buy event.

Did the Neuronetics (STIM) filing show any option or derivative exercises?

No, the filing shows no derivative transactions or remaining derivative positions. The reported activity involves only common stock, with the derivativeSummary section empty for this Form 4 submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 12:39 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		P		100,000	A	$1.17	10,553,988	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jorey Chernett	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)